Blue Jet Healthcare has announced an investment of Rs. 2,300 crore to expand its pharmaceutical manufacturing footprint in Andhra Pradesh, reinforcing India’s growing stature as a global pharmaceutical hub. The capital expenditure is expected to fund new production facilities, advanced research capabilities and export-oriented infrastructure. The move aligns with the broader push toward domestic manufacturing resilience and high-value chemical synthesis.